Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

298

HTML

2575

Figures (1-2)

215

Tables (1-1)

142

Sum=3230

Sep 28, 2010 (publication date) through May 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Sep 28, 2010; 16(36): 4515-4518
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4515

Table 1 Treatment recommendations for pancreatic neuroendocrine tumors with von Hippel-Lindau disease[12]

	Treatment recommendation
Prognostic criteria
Tumor size ≥ 3 cm
Mutation in exon 3
Tumor doubling time ≤ 500 d
None of the criteria	Followed by CT/MRI every 2-3 yr
1 criterion	Followed by CT/MRI every 6-12 mo
2 or 3 criteria	Consider surgical intervention

CT: Computed tomography; MRI: Magnetic resonance imaging.

Citation: Tamura K, Nishimori I, Ito T, Yamasaki I, Igarashi H, Shuin T. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World J Gastroenterol 2010; 16(36): 4515-4518
URL: https://www.wjgnet.com/1007-9327/full/v16/i36/4515.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i36.4515